Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 23
112
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Leishmanicidal phenolic compounds derived from Dalbergia cultrata

, , , , , , & show all
Pages 4907-4915 | Received 08 Jan 2020, Accepted 10 Mar 2020, Published online: 25 Mar 2020
 

Abstract

Leishmaniasis is a protozoan tropical infection that is estimated to be more than 0.3 million new cases occur annually worldwide. A novel phenolic compound, cultratin A (1), was isolated as a leishmanicidal constituent from the timber of Dalbergia cultrata, along with three known neoflavanoids (2, 3, 4), two benzofurans (5, 6), and two phenolic compounds (7, 8). Their structures were determined using spectral methods. Among them, a new compound (1) and 4-(S)-methoxydalbergione (2) showed effective leishmanicidal activities (IC50: 2.0 and 2.6 μM, respectively), while compound 8 showed moderate activity (IC50: 11 μM). The cytotoxicity of compounds 1 and 2 was also weaker than that of the other compounds.

Graphical Abstract

Acknowledgements

The authors would like to extend their gratitude to the Ministry of Forestry of Myanmar for providing the plant sample.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This study was supported by JSPS KAKENHI Grant Number 15K18894.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.